Insider Transactions in Q3 2024 at Mirum Pharmaceuticals, Inc. (MIRM)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2024
|
Michael G Grey |
SELL
Bona fide gift
|
Indirect |
102,788
-35.54%
|
-
|
|
Sep 18
2024
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
115
+0.07%
|
$4,255
$37.4 P/Share
|
|
Sep 11
2024
|
Eric Bjerkholt CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
18,334
+35.85%
|
-
|
|
Sep 06
2024
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
230
+0.14%
|
$9,430
$41.58 P/Share
|
|
Jul 23
2024
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
34,013
+21.15%
|
$68,026
$2.94 P/Share
|
|
Jul 02
2024
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
375
-13.39%
|
$12,750
$34.0 P/Share
|
|
Jul 01
2024
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,042
+27.11%
|
-
|